Retatrutide Prescribed Online to California Residents

Medical Weight Loss Treatment in California

Retatrutide (LY3437943) is a 39-amino acid synthetic peptide and triple receptor agonist targeting GLP-1, GIP, and glucagon receptors simultaneously. Currently in Phase 3 clinical trials (TRIUMPH program), it produced 24.2% average weight loss at 48 weeks in Phase 2 data — the highest weight reduction observed in any peptide trial to date. Listed by OmniRx for research-use only (RUO).

Key Benefits

• Triple receptor mechanism: GLP-1 + GIP + glucagon for amplified metabolic effect
• Phase 2 data shows 24.2% average weight loss at 48 weeks (12mg dose)
• ~58% hepatic fat reduction in Phase 2 sub-group analyses
• Elevated basal metabolic rate via glucagon receptor agonism
• Research-grade purity ≥98% with full CoA, HPLC, and MS documentation

Who is a Good Candidate?

Intended for laboratory researchers and pre-clinical study investigators studying triple receptor agonism, obesity mechanisms, hepatic metabolism, or GLP/GIP/glucagon signaling pathways. Listed for research-use only (RUO) — not for human therapeutic use.

Available for research use

Serving California

From Silicon Valley innovators to Central Valley farmers, Californians deserve healthcare that fits their lifestyle. OmniRx Health serves the entire Golden State—whether you're navigating LA traffic, working remotely from Lake Tahoe, or managing a vineyard in Napa. Our telehealth platform brings world-class medical expertise directly to you, eliminating the need for lengthy commutes to crowded clinics in a state where time is precious.

OmniRx Health providers are licensed by the Medical Board of California, maintaining full compliance with state telehealth regulations.

We partner with California State Board of Pharmacy licensed pharmacies across LA, San Francisco, San Diego, and statewide for convenient prescription fulfillment.

California's Telehealth Advancement Act ensures broad access to virtual care, with recent legislation permanently expanding telehealth flexibilities established during the pandemic.

California mandates telehealth parity—insurers must cover virtual visits at the same rate as in-person appointments, including Medi-Cal and commercial plans.

Frequently Asked Questions

What is retatrutide and how does it work?

Retatrutide (CAS 2381089-83-2) is a 39-amino acid synthetic peptide that simultaneously activates GLP-1, GIP, and glucagon receptors. This triple agonism produces coordinated appetite suppression (GLP-1), amplified insulin and fat-cell metabolism (GIP), and increased hepatic glucose output and resting energy expenditure (glucagon). It is currently in Phase 3 clinical trials and is available for research-use only (RUO).

How does retatrutide compare to semaglutide and tirzepatide in research?

Phase 2 data (NEJM, 2023) showed retatrutide at 12mg produced 24.2% average weight loss at 48 weeks, outperforming semaglutide (~15% at 68 weeks) and tirzepatide (~22% at 72 weeks) in their respective trials. Retatrutide adds glucagon receptor agonism — absent in both comparators — which appears to drive additional metabolic rate elevation and hepatic fat clearance.

Is retatrutide available for human use?

No. Retatrutide has not received FDA approval for any human therapeutic use. It is currently in Phase 3 (TRIUMPH) clinical trials and is listed by OmniRx strictly as a research-use only (RUO) compound for laboratory and pre-clinical research applications.

Is telehealth legal in California?

Yes, telehealth is fully legal and widely supported in California. The state has some of the most comprehensive telehealth laws in the nation, ensuring patients can access quality virtual care from licensed providers.

Can I get controlled substances via telehealth in California?

California allows telehealth providers to prescribe certain controlled substances following a proper evaluation. Our providers follow all DEA and state regulations for prescribing medications safely and legally.

Does Medi-Cal cover telehealth in California?

Yes, Medi-Cal covers telehealth services including video and audio-only visits. California has permanently expanded Medi-Cal telehealth coverage to ensure low-income residents have access to virtual care.